Creative Edge Nutrition Inc (FITX)

[sweet crude]

Ludlow Upgrades FITX to .30+

FITX Upgraded to $0.15+ on Explosive Revenue Growth
Last Updated: Sept 27, 2012 - 9:10am EST

(NEW YORK)--Creative Edge Nutrition. (OTC:FITX), a nutritional supplement company focusing on active lifestyles, was upgraded with a ‘short-term’ price target of $0.15 per share, with long-term target of $0.30 to $0.50, as new acquisitions to add $20 million+ in annual revenues.

Investor Highlights

- New Acquisitions to add $10 million in annual sales
- ROGUE on target for $6 million+ annual sales
- CENERGY Supplement line to launch Sept 27th
- Expanding online distribution through acquisitions
- Major Reduction of Available Float

To download the full report, risks, and disclosures, please visit http://www.ludlowresearch.com/reports.html

OTCQB Listing

In addition, the Company announced plans to become fully reporting, under SEC rules, and to list the common shares on the OTCQB exchange before the end of the current year.

Submit Question to Company (mailing list)

Do you have a question, comment, or inquiry to send to this company? Use the form below to submit a question to the company, receive research updates, or to be added to FITX mailing list, please register online http://www.wallstreetnewscast.com/request/fitx.htm

----------------
From report

Earnings Potential

If all were to remain equal, the ROGUE brand could be on track to report nearly $6 million+ is sales alone, but when you take into account the upcoming CENERGY supplement line launched, and their now completed acquisitions of Sci-Fit and Nature's Science brands doing around $10 million annually, then FITX could be on track to report sales revenues of $20 to $25 million+ annually, and this may be conservative itself.

If you take around 30% of those top line projections towards the bottom line, which could be achieved through cost savings in their vertical integration of their business model, you could be looking at a potential $6 million in net income. Based this on a rounded up figure of 600 million shares outstanding, and you could be looking at an EPS of around $0.01 per share. Given a Price/Earnings ratio (PE) of say 30 to 50, which is very justifiable for a fast growing company, and this would give you a conservative $0.30 to $0.50 price target.